Cat:GMP-h-TG
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-h-TG Categories , Tag

Product Details

Genemedi produces core diagnostic ingredients for test of Cancer (thyroid nodules, thyroid adenomas, multinodular goiters, thyrotoxicosis, thyroid cancer) and related syndrome. GeneMedi offers paired diagnostics grade Thyroglobulin (TG) antibodies (monoclonal antibody, mab) and antigens for Cancer (thyroid nodules, thyroid adenomas, multinodular goiters, thyrotoxicosis, thyroid cancer) rapid test kit of Thyroglobulin (TG) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Cancer (thyroid nodules, thyroid adenomas, multinodular goiters, thyrotoxicosis, thyroid cancer ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.What is a thyroglobulin test? This test measures the level of thyroglobulin in your blood. Thyroglobulin is a protein made by cells in the thyroid. The thyroid is a small, butterfly-shaped gland located near the throat. A thyroglobulin test is mostly used as a tumor marker test to help guide thyroid cancer treatment. Tumor markers, sometimes called cancer markers, are substances made by cancer cells or by normal cells in response to cancer in the body. Thyroglobulin is made by both normal and cancerous thyroid cells. The main goal of thyroid cancer treatment is to get rid of all thyroid cells. It usually involves removing the thyroid gland through surgery, followed by therapy with radioactive iodine (radioiodine). Radioiodine is a medicine used to destroy any thyroid cells that are left after surgery. It is most often given as a liquid or in a capsule. After treatment, there should be little to no thyroglobulin in the blood. Measuring thyroglobulin levels can show whether thyroid cancer cells are still in the body after treatment. Other names: Tg, TGB. thyroglobulin tumor marker What is it used for? A thyroglobulin test is mostly used to: See if thyroid cancer treatment was successful. If thyroglobulin levels stay the same or increase after treatment, it may mean there are still thyroid cancer cells in the body. If thyroglobulin levels decrease or disappear after treatment, it may mean there are no normal or cancerous thyroid cells left in the body. See if cancer has returned after successful treatment. A healthy thyroid will make thyroglobulin. So a thyroglobulin test is not used to diagnose thyroid cancer.

Product Description

Cat No. of Pruducts

GMP-h-TG-Ag01:Recombinant Human TG Protein

Product Name

Recombinant Human TG Protein

Target

Thyroglobulin

Alias of Target/Biomarker

AITD3, TGN

Expression platform

E.coli

Isotypes

Recombinant Antigen

Bioactivity validation

Thyroglobulin (TG) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in TG level test of Cancer (thyroid nodules, thyroid adenomas, multinodular goiters, thyrotoxicosis, thyroid cancer) and related syndrome evaluation

Tag

His

Products description

Recombinant Human TG Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.

Reconized/Reactive Species

Human

Purity

Purity: ≥95% (SDS-PAGE)

Application

Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Genemeidi Omicron Variant Products
test
Previous slide
Next slide

Cat No. of Pruducts

GMP-h-TG-Ab01,GMP-h-TG-Ab02:Anti-Human TG mouse monoclonal antibody (mAb)

Product Name

Anti-Human TG mouse monoclonal antibody (mAb)

Target

Thyroglobulin (TG)

Alias of Target/Biomarker

AITD3, TGN

Expression platform

Hybridoma

Isotypes

Mouse IgG

Bioactivity validation

Human Thyroglobulin (TG) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Thyroglobulin (TG) antibodies in TG level test of Cancer (thyroid nodules, thyroid adenomas, multinodular goiters, thyrotoxicosis, thyroid cancer) and related syndrome evaluation.

Tag

mFc

Products description

Anti-Human TG mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Thyroglobulin (TG) antibodies.

Reconized/Reactive Species

Human

Purity

Purity: ≥95% (SDS-PAGE)

Application

ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1

Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.